Landua, John D. http://orcid.org/0000-0002-4747-3038
Moraes, Ricardo http://orcid.org/0000-0001-5455-092X
Carpenter, Ellen M.
Lewis, Michael T. http://orcid.org/0000-0002-6330-4007
Funding for this research was provided by:
U.S. Department of the Army (DAMD 17-94-J4230)
University of California Breast Cancer Research Program (2FB-0047)
Foundation for the National Institutes of Health (PO1-CA30195, R01-CA127857)
National Cancer Institute (NCI-CA125123)
Cancer Prevention and Research Institute of Texas (RP170691)
Article History
Received: 22 April 2020
Accepted: 1 July 2020
First Online: 23 July 2020
Compliance with Ethical Standards
:
: Michael Lewis is a Founder and Limited Partner in StemMed Ltd. and a Manager of StemMed Holdings, its General Partner. He is also a Founder and equity holder in Tvardi Therapeutics Inc. John Landua, Ricardo Moraes, and Ellen Carpenter have no conflict of interest to declare.